QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)
QQQ   386.32 (-0.93%)
AAPL   189.43 (-0.95%)
MSFT   369.14 (-1.43%)
META   320.02 (-1.48%)
GOOGL   129.27 (-1.96%)
AMZN   144.84 (-1.49%)
TSLA   235.58 (-1.36%)
NVDA   455.10 (-2.68%)
NIO   7.32 (+2.38%)
BABA   73.03 (-1.30%)
AMD   118.57 (-2.32%)
T   16.67 (-0.60%)
F   10.70 (+1.13%)
MU   74.29 (-2.16%)
CGC   0.76 (+22.72%)
GE   121.50 (-0.82%)
DIS   92.01 (-0.62%)
AMC   7.50 (+9.18%)
PFE   29.25 (+1.18%)
PYPL   59.85 (+0.34%)
XOM   102.43 (-0.54%)

Sosei Group Stock Price, News & Analysis (OTCMKTS:SOLTF)

$9.48
-0.47 (-4.72%)
(As of 12/4/2023 ET)
Compare
Today's Range
$9.48
$9.71
50-Day Range
$8.93
$10.41
52-Week Range
$8.93
$22.78
Volume
1,100 shs
Average Volume
1,582 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

SOLTF stock logo

About Sosei Group Stock (OTCMKTS:SOLTF)

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of GPR35 agonist, for inflammatory bowel disease/GI disorders, which is in preclinical stage; HTL0016878 for Schizophrenia and other neuropsychiatric disorders; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; and PF-07258669 for anorexia. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, Neurocrine Biosciences, Novartis, Verily, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.

SOLTF Stock Price History

SOLTF Stock News Headlines

Sosei Group Corp 4565
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Sosei Group reports Q3 results
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Sosei Group Corp
Sosei Group Corp (4565)
See More Headlines
Receive SOLTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sosei Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:SOLTF
CIK
N/A
Fax
N/A
Employees
348
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Shinichi Tamura (Age 74)
    Founder & Chairman of the Board
    Comp: $1.54M
  • Mr. Christopher Cargill (Age 39)
    Representative Executive Officer, President, CEO & Director
    Comp: $1.32M
  • Mr. Hironoshin Nomura (Age 40)
    Executive Officer, Executive VP & CFO
  • Mr. Kieran Johnson F.C.A. (Age 54)
    Executive Officer, Executive VP & Chief Accounting Officer
  • Dr. Miles Congreve
    Chief Scientific Officer
  • Mr. Kazuhiko Yoshizumi (Age 69)
    Executive Officer, Executive VP & Chief Compliance Officer
  • Shinichiro Nishishita
    VP of Investor Relations & Head of Regulatory Disclosures
  • Stacey Southall
    Associate Director & Head of Biophysics
  • Ms. Candelle Chong (Age 34)
    Executive Officer, Executive VP & Chief of Staff
  • Dr. Satoshi Tanaka
    Executive Officer, Executive VP & President of Idorsia Pharmaceuticals Japan














SOLTF Stock Analysis - Frequently Asked Questions

Should I buy or sell Sosei Group stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sosei Group in the last twelve months. There are currently 2 sell ratings for the stock. The consensus among Wall Street analysts is that investors should "sell" SOLTF shares.
View SOLTF analyst ratings
or view top-rated stocks.

How have SOLTF shares performed in 2023?

Sosei Group's stock was trading at $15.5439 at the start of the year. Since then, SOLTF shares have decreased by 39.0% and is now trading at $9.48.
View the best growth stocks for 2023 here
.

Are investors shorting Sosei Group?

Sosei Group saw a decline in short interest in November. As of November 15th, there was short interest totaling 1,062,100 shares, a decline of 29.0% from the October 31st total of 1,495,200 shares. Based on an average daily volume of 200 shares, the days-to-cover ratio is currently 5,310.5 days.
View Sosei Group's Short Interest
.

How do I buy shares of Sosei Group?

Shares of SOLTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:SOLTF) was last updated on 12/4/2023 by MarketBeat.com Staff

My Account -